CURX vs NIO · $8.9M cap vs rev $12.51B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US. It is led by Bin Li.
CURX does not have a complete income-statement cache yet.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
CURX currently screens at market cap $8.9M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the CURX and NIO stock pages for the full models.
Not investment advice.